Cargando…

Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy

Background: Carfilzomib, the proteasome inhibitor, can increase the overall survival rate of multiple myeloma (MM) patients undergoing targeted therapy. However, relapse and toxicity present great challenges for such treatment, so an urgent need for effective combination therapy is necessary. Emodin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chin-Mu, Yen, Chia-Hung, Wang, Shu-Chen, Liu, Yi-Chang, Huang, Chien-Tzu, Wang, Min-Hong, Chuang, Tzer-Ming, Ke, Ya-Lun, Yeh, Tsung-Jang, Gau, Yuh-Ching, Du, Jeng-Shiun, Wang, Hui-Ching, Cho, Shih-Feng, Tsai, Yuhsin, Hsiao, Chi-En, Hsiao, Samuel Yien, Hsiao, Hui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312579/ https://www.ncbi.nlm.nih.gov/pubmed/35884943 http://dx.doi.org/10.3390/biomedicines10071638

Ejemplares similares

Pathogenesis and Treatment of Myeloma-Related Bone Disease
por: Gau, Yuh-Ching, et al.
Publicado: (2022)

The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
por: Du, Jeng-Shiun, et al.
Publicado: (2022)

High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach
por: Hsu, Chin-Mu, et al.
Publicado: (2023)

Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study
por: Chuang, Tzer-Ming, et al.
Publicado: (2021)

Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
por: Yeh, Tsung-Jang, et al.
Publicado: (2022)

Calreticulin Mutation Survey by High Resolution Melting Method Associated with Unique Presentations in Essential Thrombocythemic Patients
por: Liu, Yi-Chang, et al.
Publicado: (2020)

Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
por: Wang, Hui-Ching, et al.
Publicado: (2021)

Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
por: Yeh, Tsung-Jang, et al.
Publicado: (2023)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Management of Myeloma Bone Lesions
por: Du, Jeng-Shiun, et al.
Publicado: (2021)

Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2
por: Yen, Chia-Hung, et al.
Publicado: (2020)

Carfilzomib for relapsed and refractory multiple myeloma
por: Groen, K, et al.
Publicado: (2019)

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
por: Gasparetto, Cristina, et al.
Publicado: (2021)

Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Liu, Yi-Chang, et al.
Publicado: (2021)

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
por: Rosenthal, A, et al.
Publicado: (2016)

Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
por: Español, Ignacio, et al.
Publicado: (2017)

Optimizing carfilzomib use in multiple myeloma treatment
por: Yoon, Sung-Soo
Publicado: (2019)

The role of carfilzomib in relapsed/refractory multiple myeloma
por: Yee, Andrew J.
Publicado: (2021)

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
por: Badros, A Z, et al.
Publicado: (2013)

Astragalus membranaceus Improves Exercise Performance and Ameliorates Exercise-Induced Fatigue in Trained Mice
por: Yeh, Tzu-Shao, et al.
Publicado: (2014)

New drugs in multiple myeloma – role of carfilzomib and pomalidomide
por: Jurczyszyn, Artur, et al.
Publicado: (2014)

Targeted treatments for multiple myeloma: specific role of carfilzomib
por: Sugumar, Dhivya, et al.
Publicado: (2015)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Carfilzomib boosted combination therapy for relapsed multiple myeloma
por: Steiner, Raphael E, et al.
Publicado: (2017)

Carfilzomib induced cardiotoxicity in a multiple myeloma patient
por: Méndez-Toro, Arnold, et al.
Publicado: (2020)

Carfilzomib-associated pulmonary arterial hypertension in multiple myeloma
por: Yang, Jenny Z., et al.
Publicado: (2021)

Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71
por: Lin, Cheng-Wen, et al.
Publicado: (2008)

Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions
por: Wu, Chung-Chun, et al.
Publicado: (2023)

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
por: Facon, Thierry, et al.
Publicado: (2022)

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma
por: Fostier, Karel, et al.
Publicado: (2012)

Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib
por: Liberman, Vladimir, et al.
Publicado: (2016)

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma
por: Jain, Tania, et al.
Publicado: (2017)

Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma
por: Ikoma, Takenori, et al.
Publicado: (2019)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
por: Landgren, Ola, et al.
Publicado: (2019)

Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study
por: Wang, Hui-Ching, et al.
Publicado: (2020)

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies
por: Huang, Chien-Tzu, et al.
Publicado: (2023)

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study
por: Astarita, Anna, et al.
Publicado: (2023)

Necessity of Local Modification for Deep Learning Algorithms to Predict Diabetic Retinopathy
por: Tsai, Ching-Yao, et al.
Publicado: (2022)

Anti-inflammatory effect of longan seed extract in carrageenan stimulated Sprague-Dawley rats
por: Lee, Ching-Hsiao, et al.
Publicado: (2016)

TBS Predict Coronary Artery Calcification in Adults
por: Chuang, Tzyy-Ling, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gdqqtv8jncs97b5g69g26c6a1l